Harris Martin reported that a U.S. district judge threw out a patient's lawsuit alleging that U.K. orthopedics giant Smith & Nephew's metal hip replacement left her in pain, disabled and needing replacement surgery.
U.K. orthopedics giant Smith & Nephew has been riding its checkbook into emerging markets all year, and now the company has signed a deal to pick up a share of its Brazilian wound care partner with an eye on vertical integration.
Smith & Nephew has named a new chairman, and the British device company generated encouraging numbers for its 2013 third-quarter revenue.
Smith & Nephew's long-time chairman Sir John Buchananis planning to retire, Sky News reported, a move coming as the device company transitions away from its traditional reliance on orthopedic implants.
Georgia's Femasys will use international device giant Smith & Nephew to advance national distribution in the U.S. of one of its signature women's health diagnostic devices.
Smith & Nephew won another round in long-standing patent fight against rival Arthrex. A federal judge has ordered the Florida device maker to stop selling two surgical device product lines at the center of their dispute. But Arthrex, after many appeals, said it is continuing the fight.
Stryker, Johnson & Johnson, Wright Medical, Smith & Nephew, Zimmer: Each makes heavily scrutinized hip and knee implants, but none offers a warranty to protect patients if something goes awry.
Smith & Nephew, like most orthopedic device outfits, will need to diversify if it wants to grow, and CEO Olivier Bohuon has a green light and a heap of cash to make that a reality, hunting for buyouts around the globe.
Smith & Nephew has turned its eye toward wound care and emerging markets in recent months, and the strategy is paying off.
Smith & Nephew is pursuing a massive share repurchasing program and continuing a quest for new acquisitions.